NHLBI Program Project Applications (P01 Clinical Trials Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a funding opportunity for Program Project Applications (P01) through the National Heart, Lung, and Blood Institute (NHLBI) to support innovative research on heart, lung, blood, and sleep disorders. Applicants are required to propose a minimum of three interrelated research projects centered around a common biomedical theme, with the option to include a project led by an Early Stage Investigator (ESI). This initiative aims to foster interdisciplinary collaboration and accelerate scientific knowledge acquisition, particularly encouraging participation from underrepresented groups in research. The maximum funding available is $1,515,000 in direct costs annually, with ESI-led projects eligible for up to $1,765,000. The application deadline is January 25, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-065.html.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.